The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dubinett Howard since year 2005.
The trader's CIK number is 1189454.
At the time of this reporting, Dubinett Howard is the Executive VP, COO of Bio Reference Laboratories Inc .
(stock ticker symbol BRLI).
See this page for all insider trading activities at Bio Reference Laboratories Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-09-13||BRLI||Bio Reference Laboratories Inc||Sale||20,000||29.40||588,020|
|2012-12-18||BRLI||Bio Reference Laboratories Inc||Sale||10,000||29.66||296,620|
|2011-12-12||BRLI||Bio Reference Laboratories Inc||Buy||10,000||14.24||142,400|
|2011-04-26||BRLI||Bio Reference Laboratories Inc||Sale||432||23.75||10,260|
|2011-04-27||BRLI||Bio Reference Laboratories Inc||Sale||9,268||23.75||220,115|
|2011-04-21||BRLI||Bio Reference Laboratories Inc||Sale||300||23.78||7,134|
|2011-01-14||BRLI||Bio Reference Laboratories Inc||Sale||10,000||23.72||237,200|
|2010-10-15||BRLI||Bio Reference Laboratories Inc||Sale||10,000||21.48||214,800|
|2010-09-27||BRLI||Bio Reference Laboratories Inc||Sale||10,000||21.00||210,000|
|2010-06-11||BRLI||Bio Reference Laboratories Inc||Sale||10,000||23.05||230,460|
|2010-06-14||BRLI||Bio Reference Laboratories Inc||Sale||15,000||23.43||351,510|
|2010-03-11||BRLI||Bio Reference Laboratories Inc||Sale||10,000||44.97||449,700|
|2009-10-19||BRLI||Bio Reference Laboratories Inc||Sale||85,803||29.98||2,572,373|
|2007-09-28||BRLI||Bio Reference Laboratories Inc||Sale||79,644||17.26||1,374,655|
|2006-03-30||BRLI||Bio Reference Laboratories Inc||Sale||90,485||14.34||1,297,554|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dubinett Howard (Executive VP, COO of Bio Reference Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.